Nearly 24 million Americans have Medicare coverage, says HHS Secretary

30 January 2006

In the USA, nearly 24 million Medicare beneficiaries now have prescription drug coverage, including more than 2.6 million people who signed up for the new stand-alone prescription drug coverage in the last 30 days, according to a US Department of Health and Human Services statement on January 17. This number comes on top of the 1 million who enrolled in stand-alone plans in the first 30 days of the program.

"Enrollment in the new Medicare drug benefit is exceeding our expectations and keeping us on track to reach our goal of 28 to 30 million enrollees in the first year," said HHS Secretary Mike Leavitt, adding: "we are filling a million prescriptions a day, and seniors are saying the benefit is saving them money."

While the system is working for most seniors, Mr Leavitt said some seniors are experiencing problems getting their prescriptions filled and added: "we are working as quickly as possible to resolve these problems, and no senior should leave the pharmacy without the prescription drugs they need."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight